Literature DB >> 3380801

Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.

D Plaksin1, C Gelber, M Feldman, L Eisenbach.   

Abstract

High metastatic clones of the murine 3LL carcinoma express greatly reduced levels of H-2Kb major histocompatibility complex class I antigens, while low metastatic clones of the same tumor express high levels of H-2Kb. Induced expression of this antigen after transfection with the H-2Kb gene resulted in conversion of a metastatic to a non- or low-metastatic phenotype. Unlike the parental cells, transfected cells are potent inducers of H-2Kb-restricted syngeneic cytotoxic lymphocytes that kill the Kb-positive clones and cross-react with parental nontransfected cells. Preimmunization of mice with Kb-positive transfectants conferred protection against metastatic spread of malignant cells. Moreover, immunotherapy of metastasis was achieved by immunization with the H-2Kb-transfected cells of animals already carrying a growing local tumor of the parental cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380801      PMCID: PMC280450          DOI: 10.1073/pnas.85.12.4463

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.

Authors:  M G Masucci; S Torsteindottir; J Colombani; C Brautbar; E Klein; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 3.  Variation in MHC antigenic profiles of tumor cells and its biological effects.

Authors:  H Festenstein; W Schmidt
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

Review 4.  Mouse teratocarcinoma and embryonic antigens.

Authors:  F Jacob
Journal:  Immunol Rev       Date:  1977-01       Impact factor: 12.988

Review 5.  Major histocompatibility complex restricted cell-mediated immunity.

Authors:  G M Shearer; A M Schmitt-Verhulst
Journal:  Adv Immunol       Date:  1977       Impact factor: 3.543

6.  Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties.

Authors:  P De Baetselier; S Katzav; E Gorelik; M Feldman; S Segal
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

7.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

8.  Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.

Authors:  N Isakov; M Feldman; S Segal
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  The DNA sequence of the H-2kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibilty antigens.

Authors:  E Weiss; L Golden; R Zakut; A Mellor; K Fahrner; S Kvist; R A Flavell
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  14 in total

1.  Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences.

Authors:  S Y Choi; K van de Mark; D V Faller
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

Review 2.  Potential applications of gene therapy in the patient with cancer.

Authors:  P W Szlosarek; A G Dalgleish
Journal:  Drugs Aging       Date:  2000-08       Impact factor: 3.923

3.  Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles.

Authors:  Bei Cheng; Feng Gao; Erica Maissy; Peisheng Xu
Journal:  Acta Biomater       Date:  2018-12-05       Impact factor: 8.947

4.  Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.

Authors:  C Andrew Stewart; Hannah Metheny; Noriho Iida; Loretta Smith; Miranda Hanson; Folkert Steinhagen; Robert M Leighty; Axel Roers; Christopher L Karp; Werner Müller; Giorgio Trinchieri
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

5.  Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.

Authors:  E Gorelik; M Kim; L Duty; T Henion; U Galili
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

6.  HLA Class I Expressions on Peripheral Blood Mononuclear Cells in Colorectal Cancer Patients.

Authors:  Zhi-Mian Zhang; Xiao Guan; Ying-Jie Li; Ming-Chen Zhu; Xiao-Jing Yang; Xiong Zou
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

7.  Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.

Authors:  T VandenDriessche; M Bakkus; D Toussaint-Demylle; K Thielemans; H Verschueren; P De Baetselier
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

8.  Expression of ganglioside GM3 and H-2 antigens in clones with different metastatic and growth potentials isolated from Lewis lung carcinoma (3LL) cell line.

Authors:  J Inokuchi; M Jimbo; Y Kumamoto; H Shimeno; A Nagamatsu
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

9.  Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL).

Authors:  L Tentori; C Leonetti; F Lozupone; E Bonmassar
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

10.  A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice.

Authors:  Yifat Merbl; Royi Itzchak; Tal Vider-Shalit; Yoram Louzoun; Francisco J Quintana; Ezra Vadai; Lea Eisenbach; Irun R Cohen
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.